It was found that bromocoumarinplatin 1 could also activate p53 protein to enhance the anticancer activity and overcome the resistance of cisplatin through the p53 pathway.179 Diplatin, a novel platinum complex, had shown that the antitumor activity of diplatin against lung cancer cell lines was superior to that of carboplatin. This evidence concerns the gene TP53 and lung carcinoma.